Therefore, clinicians must set realistic expectations when initiating GLP-1based adjunct treatment in type 1 diabetes
Average reduction in waist size Patients say it's the best treatment they've tried Of patients achieve lasting weight loss Based on patient outcomes at Blue Medi Spa Individual results vary Patient story From a Size 14 to a Size 4 and Feeling Better Than Ever
Did metabolic markers improve
Companies can make pretty much whatever claims they want, as long as they have the disclaimer: While GLP-1 agonist medications are very powerful in slowing digestion and curbing appetite, there are no supplements or foods that have an effect that even approaches them
The majority of current users have a primary diagnosis of type 2 diabetes, while a growing proportion are using these medications primarily for weight management
The Obesity Medicine Association (OMA) will host its annual conference, Obesity Medicine 2025, from April 23-27, 2025, in National Harbor, Maryland